Picture of Korsana Biosciences logo

KRSA — Korsana Biosciences News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapNeutral

Brief: Cyclerion Therapeutics Says Net Loss Was About $20 Million For Q2

Aug 3 (Reuters) - Cyclerion Therapeutics Inc  CYCN.O :
    * CYCLERION THERAPEUTICS REPORTS SECOND QUARTER 2020
FINANCIAL
RESULTS AND RECENT CORPORATE HIGHLIGHTS
    * CYCLERION THERAPEUTICS INC - REVENUE WAS $0.7 MILLION FOR
Q2
2020, AS COMPARED TO $1.6 MILLION
    * CYCLERION THERAPEUTICS INC - NET LOSS WAS APPROXIMATELY
$20
MILLION FOR Q2 OF 2020

Source text for Eikon:  ID:nGNX8WZR0P 
Further company coverage:  CYCN.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Korsana Biosciences

See all news